As researchers continue to investigate the potential of oral GLP-1 receptor agonists, the landscape of diabetes treatment could change dramatically
Whether you are navigating a demanding career in Toronto or managing a busy household in Vancouver, finding ways to support your resilience is a common goal
HF is closely related to cardiometabolic diseases such as diabetes, obesity and chronic kidney disease, and strategies that address most or all these intertwined conditions are desirable
For these reasons, GLP-1RA are increasingly popular options for glycemic control and weight management in patients with obesity and type 2 diabetes (Camilleri and Lupianez-Merly 2023
The same low-grade, chronic inflammation that links visceral fat to disease also drives the gradual stiffening and dysfunction of arteries (a process called inflammaging)
Pons R, De Vivo DC: Primary and secondary carnitine deficiency syndromes